Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06359990 · ClinicalTrials.gov registry record · NA
BrotherlyACT: A Tech-Enhanced Violence and Substance Use Intervention for Black Boys and Young Men
A NA study of Substance Use and Violence in Adolescence, sponsored by Rush University Medical Center.
- Active
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT06359990: Active NA study of Substance Use and Violence in Adolescence, sponsored by Rush University Medical Center.
NCT06359990 is a NA study of Substance Use and Violence in Adolescence that is active but no longer recruiting, run by Rush University Medical Center. The registered enrollment target is 300 participants, below the 1,257-participant average among 88 other Substance Use trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06359990, a NA study of Substance Use and Violence in Adolescence, is active but no longer recruiting, sponsored by Rush University Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will adapt and test a culturally tailored, multi-component, and trauma-focused digital intervention to reduce the risk and effects of youth violence and substance use and bridge service access gaps for young Black males (YBM) in pediatric emergency and community-based low-resource settings.
Primary Outcome
Change in the perpetration of youth and peer aggression from baseline to follow-up measured with the Reactive-Proactive Aggression Questionnaire (RPQ; Raine et al., 2006) measures two dimensions of aggression in physical or verbal forms. Scores (0, 1, or 2) for proactive aggression items (2,4,6,9,10,12,15, 17,18,20,21,23) and reactive items (1, 3, 5,7,8,11, 13,14, 16,19,22) are summated to form proactive and reactive scales. Proactive and reactive scale scores are summated to obtain total aggres
Conditions Studied
Interventions
- BEHAVIORAL BrotherlyACT
- OTHER BrotherlyACT Waitlist Control Group (WCG)
Study Locations (1)
Illinois
- Rush University Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2024-02-15 |
| Est. Completion | 2027-02-15 |
| Phase | NA |
What the registry record for NCT06359990 still lists
NCT06359990 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 1,257-participant average among 88 other Substance Use trials with a reported enrollment target (76% lower).
The record links to 3 conditions, with Substance Use appearing as the primary indexed condition, and to 2 interventions - of which BrotherlyACT is the first listed.
NCT06359990 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06359990 about?
NCT06359990 is a clinical study titled "BrotherlyACT: A Tech-Enhanced Violence and Substance Use Intervention for Black Boys and Young Men". This study will adapt and test a culturally tailored, multi-component, and trauma-focused digital intervention to reduce the risk and effects of youth violence and substance use and bridge service access gaps for young Black males (YBM) in pediatric emergency and community-based low-resource setting...
What is the current status of trial NCT06359990?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2024-02-15. Estimated completion is 2027-02-15.
What conditions does trial NCT06359990 study?
This clinical trial studies the following conditions: Substance Use, Violence in Adolescence, Avoidance of Healthcare.
What interventions are being tested in trial NCT06359990?
The interventions under investigation include: BrotherlyACT (BEHAVIORAL), BrotherlyACT Waitlist Control Group (WCG) (OTHER).
Who is sponsoring clinical trial NCT06359990?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06359990 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06359990's enrollment target sits among peer trials
300 31st of 88 higher than 54 of 88 other Substance Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Native Spirit: Significant Aim 3: Intervention
RECRUITING · NA
-
Parent SMART (Substance Misuse in Adolescents in Residential Treatment)
RECRUITING · NA
-
Cultural Adaptation of Drug Treatment for DJJ Youth
RECRUITING · NA
-
Adaptation and Evaluation of Bright Horizons
RECRUITING · NA
-
Teen Health Choices & Wellness
RECRUITING · NA
-
Pre-exposure Prophylaxis (PrEP) Uptake and Adherence Intervention for Women with Trauma-related Conditions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI